Tabula Rasa HealthCare Inc (NASDAQ:TRHC) CFO Brian W. Adams purchased 5,391 shares of Tabula Rasa HealthCare stock in a transaction dated Friday, January 12th. The shares were bought at an average price of $14.23 per share, for a total transaction of $76,713.93. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) opened at $34.14 on Friday. The firm has a market capitalization of $600.98, a P/E ratio of -136.56, a P/E/G ratio of 3.51 and a beta of 3.20. Tabula Rasa HealthCare Inc has a 52 week low of $11.59 and a 52 week high of $36.80. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.66 and a current ratio of 0.73.
Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its earnings results on Monday, November 6th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.02. The firm had revenue of $33.27 million during the quarter, compared to analysts’ expectations of $31.76 million. Tabula Rasa HealthCare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The firm’s revenue was up 37.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.06 earnings per share. analysts forecast that Tabula Rasa HealthCare Inc will post 0.03 EPS for the current year.
Several research firms have recently commented on TRHC. First Analysis began coverage on Tabula Rasa HealthCare in a report on Wednesday, November 1st. They set an “overweight” rating and a $41.00 price target on the stock. Piper Jaffray Companies reiterated an “overweight” rating and set a $35.00 price target on shares of Tabula Rasa HealthCare in a report on Tuesday, November 7th. They noted that the move was a valuation call. William Blair began coverage on Tabula Rasa HealthCare in a report on Monday, December 11th. They set an “outperform” rating on the stock. BidaskClub lowered Tabula Rasa HealthCare from a “strong-buy” rating to a “buy” rating in a report on Wednesday, December 6th. Finally, Zacks Investment Research upgraded Tabula Rasa HealthCare from a “hold” rating to a “strong-buy” rating and set a $31.00 price target on the stock in a report on Wednesday, October 11th. Two equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. Tabula Rasa HealthCare presently has an average rating of “Buy” and an average target price of $29.78.
A number of hedge funds have recently bought and sold shares of TRHC. Bank of New York Mellon Corp lifted its stake in Tabula Rasa HealthCare by 47.2% during the second quarter. Bank of New York Mellon Corp now owns 19,412 shares of the company’s stock worth $293,000 after purchasing an additional 6,228 shares during the last quarter. Teachers Advisors LLC lifted its stake in Tabula Rasa HealthCare by 203.5% during the second quarter. Teachers Advisors LLC now owns 16,500 shares of the company’s stock worth $248,000 after purchasing an additional 11,063 shares during the last quarter. TIAA CREF Investment Management LLC lifted its stake in Tabula Rasa HealthCare by 206.4% during the second quarter. TIAA CREF Investment Management LLC now owns 24,913 shares of the company’s stock worth $375,000 after purchasing an additional 16,782 shares during the last quarter. New York State Common Retirement Fund lifted its stake in Tabula Rasa HealthCare by 257.0% during the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock worth $151,000 after purchasing an additional 7,199 shares during the last quarter. Finally, Northern Trust Corp lifted its stake in Tabula Rasa HealthCare by 97.4% during the second quarter. Northern Trust Corp now owns 95,862 shares of the company’s stock worth $1,443,000 after purchasing an additional 47,306 shares during the last quarter. Hedge funds and other institutional investors own 31.85% of the company’s stock.
WARNING: This article was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/19/brian-w-adams-purchases-5391-shares-of-tabula-rasa-healthcare-inc-trhc-stock.html.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.